Contact Us
Plans & Services Health & Wellness About Wellmark Member Employer Broker Provider
Home Provider Medical Policies & Authorizations Alphabetical Listing
» Register for Wellmark.com
» Claims & Payment
» Communication & Resources
» Credentialing & Enrollment
» Health Management
» Medical, Dental, & Pharmacy
» Medical Policies & Authorizations
 Printer-Friendly Page

Computed Tomography (CT) and Computed Tomography Angiography (CTA) for Coronary Artery Evaluation

» Summary » Procedure Codes
» Description » Selected References
» Prior Approval » Policy History
» Policy
 

Medical Policy: 06.01.20 
Original Effective Date: October 2005 
Reviewed: September 2011 
Revised: March 2007 


Benefit Application
Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions may apply. Benefits may vary based on contract, and individual member benefits must be verified. Wellmark determines medical necessity only if the benefit exists and no contract exclusions are applicable. This medical policy may not apply to FEP. Benefits are determined by the Federal Employee Program.

This Medical Policy document describes the status of medical technology at the time the document was developed. Since that time, new technology may have emerged or new medical literature may have been published. This Medical Policy will be reviewed regularly and be updated as scientific and medical literature becomes available.


Description: 

Computed tomography (CT) combines multiple x-ray images with the assistance of a computer to produce cross-sectional views of the body. Cardiac CT is a heart-specific imaging technology with or without contrast used to visualize heart anatomy, coronary circulation, and great vessels.

 

Computed tomography angiography (CTA) is the use of computed tomography scanners and injected contrast agents to obtain images of blood vessels and diagnose existing coronary artery disease (CAD). Multislice or multidetector scanners (MSCT) rotate faster than early electron beam computed tomography scanners and have 64-slice, and greater, image capability per rotation, resulting in increased speed and improved spatial and temporal high-resolution images.

The image quality of multislice scans is improved when the patient’s heart rate is less than sixty-five beats per minute. To achieve a heart rate less than sixty-five beats per minute current clinical practice is to medicate the patient with an oral or intravenous beta blocker. Calcium channel blockers may be used if the patient has a contraindication to beta blockers. Patient exposure to radiation is a concern with multi-slice computed tomography, which administers approximately twice the radiation dose of invasive coronary angiography. However, the relative risk of mortality with MSCT is approximately half that of invasive coronary angiography.

 
The evaluation of coronary artery calcium as a screening test is addressed in policy 06.01.06; Quantitative Coronary Artery Calcium Scoring as a Screening Test.

Top


Prior Approval: 

 

Not applicable


Top


Policy: 

Cardiac computed tomography (CT) may be considered medically necessary for any of the following indications:

  • Evaluation of intra- and extra-cardiac structures in patients with:
    • Suspected cardiac mass (i.e., tumor or thrombus)
    • Technically limited images from echocardiograms, MRI, or TEE
    • Pericardial conditions (i.e., pericardial mass, constrictive pericarditis, or complications of cardiac surgery)
    • Atrial fibrillation who are being considered for invasive radiofrequency ablation to evaluate pulmonary vein anatomy                                                      
    • Non-invasive coronary vein mapping prior to placement of a biventricular pacemaker
    • Noninvasive coronary arterial mapping, including internal mammary artery prior to repeat cardiac surgical revascularization

Computed tomography angiography (CTA) may be considered medically necessary to evaluate the coronary arteries for any of the following indications:

  • Evaluation of acute chest pain in patients with:
    • Intermediate pre-test probability of coronary artery disease
    • No EKG changes
    • Serial enzymes negative
  • Evaluation of chest pain syndrome in patients with:
    • Intermediate probability of coronary artery disease
    • EKG uninterpretable
    • Patient unable to exercise
    • Prior uninterpretable or equivocal stress test (exercise, perfusion or stress echo) who require further evaluation
  • Evaluation of intracardiac structures in patients with:
    • Suspected coronary anomalies
  • Evaluation of cardiac structure and morphology to:
    • Assess complex congenital heart disease including anomalies of coronary circulation, great vessels, and cardiac chambers and valves
    • Evaluate coronary arteries in patients with new onset heart failure to assess etiology
    • Evaluate coronary arteries prior to non-coronary cardiac surgery
  • Evaluation of aortic and pulmonary disease in patients with:
    • Suspected aortic dissection or thoracic aortic aneurysm
    • Suspected pulmonary embolism

Based upon appropriateness criteria from a multidisciplinary cardiac CTA and cardiac MRI work group, computed tomographic angiography is considered investigational for all other indications including:

  • Evaluation of chest pain in patients with:
    • High pre-test probability of coronary artery disease or;
    • Evidence of moderate to severe ischemia on stress test (i.e., exercise, perfusion, or stress echo); or
    • Intermediate pre-test probability of coronary heart disease with an interpretable EKG and are able to exercise
  • Evaluation of acute chest pain in patients with
    • High pre-test probability of coronary artery disease
    • EKG-ST-segment elevation and/or
    • Positive cardiac enzymes
  • Evaluation of acute chest pain in patients with:
    • Low pre-test probability of coronary heart disease
    • No EKG changes
    • Negative serial enzymes
  • Detection of coronary artery disease in asymptomatic patients
  • Risk assessment of asymptomatic patients with prior test results when:
    • There is high risk of coronary heart disease (based on Framingham criteria)
    • No significant obstructive disease was evident on cardiac CTA or invasive angiogram performed within the previous 2 years
  • Preoperative evaluation for non-cardiac surgery
  • Post-revascularization evaluation of bypass grafts and coronary anatomy after CABG
  • Post-revascularization for in-stent restenosis after percutaneous coronary intervention (PCI)
  • Evaluation of left ventricular (LV) function:
    • In patients following myocardial infarction
    • In patients with heart failure
  • Characterization of native and prosthetic cardiac valves

 

Top


Procedure Codes and Billing Guidelines: 

To report provider services, use appropriate CPT* codes, Modifiers, Alpha Numeric (HCPCS) level 2) codes, Revenue codes, and/or ICD-9-CM diagnostic codes.
  • 75572 Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)
  • 75573  Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology in the setting of congenital heart disease (including 3D image postprocessing, assessment of LV cardiac function, RV structure and function and evaluation of venous structures, if performed)
  • 75574 Computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with contrast material, including 3D image postprocessing (including evaluation of cardiac structure and morphology, assessment of cardiac function, and evaluation of venous structures, if performed)  

Top


Selected References: 

  • Leber AW, Knez A, Becker C et al. Non-invasive intravenous coronary angiography using electron beam tomography and multi-slice computed tomography. Heart. 2003; 89(6):633-9.
  • Achenbach S, Ropers D, Regenfus M et al. Noninvasive coronary angiography by magnetic resonance imaging, electron-beam computed tomography, and multi-slice computed tomography. Am J Cardiol. 2001; 88(2A):70E-73E.
  • Mollet NR, Cademartiri, F, Nieman K et al. Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris. J Am Coll Cardiol. 2004; 43(12):2265-70.
  • Maruyama T, Yoshizumi T, Tamura R et al. Comparison of visibility and diagnostic capability of noninvasive coronary angiography by eight-slice multidetector-row computed tomography versus conventional coronary angiography. Am J Cardiol. 2004; 93(5):537-42.
  • Raff GL, Gallagher MJ, O'Neill WW, Goldstein JA. Diagnostic Accuracy of Noninvasive Coronary Angiography Using 64-Slice Sprial Computed Tomography. J Am Coll Cardiol. 2005; 46(3)552-7.
  • Hoffman MHK, Heshui S, Schmitz BL et al. Noninvasive Coronary Angiography With Multislice Computed Tomography. JAMA. 2005; 293(20):2471-8.
  • Blue Cross and Blue Shield Association. Contrast-Enhanced Cardiac Computed Tomographic Angiography for Coronary Artery Evaluation. Technology Evaluation Center. Assessment Program 2005; 20(4).
  • Schoenhagen P, Stillman A, Garcia M et al. Coronary artery imaging with multidetector computed tomography: A call for an evidence-based, multidisciplinary approach. Am Heart J 2006 May; 151(5):945-8.
  • Fine JJ, Hopkins CB, Ruff N et al. Comparison of Accuracy of 64-slice Cardiovascular Computed Tomography with Coronary Angiography in Patients with Suspected Coronary Artery Disease. Am J Cardiol 2006 Jan; 97(2):173-4.
  • Ropers D, Rixe J, Anders K et al. Usefulness of Multidetector Row Spiral Computed Tomography With 64- × 0.6-mm Collimation and 330-ms Rotation for the Noninvasive Detection of Significant Coronary Artery Stenoses.  Am J Cardiol 2006 Feb; 97(3):343-348.
  • Mollet NR, Cademartiri F, van Mieghem CAG et al. High-Resolution Spiral Computed Tomography Coronary Angiography in Patients referred for Diagnostic Conventional Coronary Angiography. Circulation. 2005; 112:2318-2323.
  • Leschka S, Alkadhi H, Plass A et al. Accuracy of MSCT coronary angiography with 64-slice technology: a first experience. Eur Heart J. Aug 2005; 26(15):1451-3.
  • Stein PD, Beemath A Kayali F et al. Multidetector Computed Tomography for the Diagnosis of Coronary Artery Disease: A Systematic Review. Am J Med. 2006 Mar; 119(3):203-16.
  • Agency for Healthcare Research and Quality. Technology Assessment Program. Non-Invasive Imaging for Coronary Artery Disease. April 28, 2006.
  • Blue Cross Blue Shield Association. Technology Evaluation Center. Contrast-Enhanced Cardiac Computed Tomographic Angiography in the Diagnosis of Coronary Artery Stenosis or for Evaluation of Acute Chest Pain. TEC Assessment Program 2006 Aug; 21(5).
  • Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR Appropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging. J Am Coll Cardiol 2006 Oct; 48(7):1475-97.
  • Jacobs JE, Boxt LM, Desjardins B et al. ACR Practice Guideline for the Performance and Interpretation of Cardiac Computed Tomography. J Am Coll Radiol 2006;48(3):677-685.
  • Jones CM, Athanasiou T, Dunne N et al. Multi-detector computed tomography in coronary artery bypass graft assessment: a meta-analysis. Ann Thorac Surg. 2007 Jan;83(1):341-8.
  • Hamon M, Biondi-Zoccai GG, Malagutti P et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol 2006;48(9):1896-910.
  • Mark DB, Berman DS, Budoff MJ et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010;55:2663-99.
  • Raff GL, Chinnaiyan KM, Share DM et al. Radiation dose from cardiac computed tomography before and after implementation of radiation dose-reduction techniques. JAMA. 2009;301:2340-8.
  • Kim JW, Kang EY, Yong HS et al. Incidental extracardiac findings at cardiac CT angiography: comparison of prevalence and clinical significance between precontrast low-dose whole thoracic scan and postcontrast retrospective ECG-gated cardiac scan. Int J Cardiovasc Imaging. 2009;25 Suppl 1:75-81.
  • Bamberg F, Sommer WH, Hoffmann V et al. Meta-analysis and systematic review of the long-term predictive value of assessment of coronary atherosclerosis by contrast-enhanced coronary computed tomography angiography. J Am Coll Cardiol 2011;57(24):2426-36. 

Top


Policy History: 

 

 

Date                                        Reason                               Action

September 2011                     Annual review                     Policy renewed


Top


Wellmark medical policies address the complex issue of technology assessment of new and emerging treatments, devices, drugs, etc.   They are developed to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. Wellmark medical policies contain only a partial, general description of plan or program benefits and do not constitute a contract. Wellmark does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Wellmark or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. Our medical policies may be updated and therefore are subject to change without notice.

*Current Procedural Terminology © 2010 American Medical Association. All Rights Reserved.

 
Contact Information
New information or technology that would be relevant for Wellmark to consider when this policy is next reviewed may be submitted to:
  Wellmark Blue Cross and Blue Shield
  Medical Policy Analyst
  P.O. Box 9232
  Des Moines, IA 50306-9232
Like Us facebook      Follow Us twitter      Watch Us youtube
 

 

© 2012 Wellmark, Inc. All Rights Reserved.
Wellmark Blue Cross and Blue Shield is an Independent Licensee of the Blue Cross and Blue Shield Association doing business in Iowa and South Dakota.
 
Privacy & Legal  |  Browser Information